November 4, 2015 | Israeli medical device company, Lumenis, has acquired the Israeli aesthetic company Pollogen. No financial details regarding the deal were disclosed, but Lumenis said in a statement that Pollogen will strengthen its position in the cosmetic segment with its advanced solutions in radio-frequency technology. Early this year, Lumenis de-listed from the Nasdaq when Chinese firm XIO acquired it for $510 million.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments